Leadership
Adapt or Die: Nine Lessons from the Battlefield
For Rick Lynch, the General who led the Iraqi 'surge' campaign, a key consideration in sustaining pharma as a thriving business of this is effective, adaptive leadership. Here he cites nine lessons from his long Army history that pharma leaders can apply in today's come-from-behind struggle for market share... Read more |
Leadership
Pharm Exec's Emerging Pharma Leaders 2015: Nominate Now!
It's time for you to tell us who you think should receive Pharm Exec's 2015 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague – or yourself ... Read more
|
US
After Hamburg: What Next for FDA?
Following Commissioner Margaret Hamburg's announcement that she is to leave FDA in March, Jill Wechsler looks at her achievements and considers the new candidates for the job ... Read more
|
Asia
South Korea: An Emerging Clinical Trials Market?
A new analysis shows South Korea to be the most attractive early phase destination based on the availability of global and regional suppliers, patient pool and the current regulatory scenario of the country ... Read more
|
Forecast
Pharm Exec's 2015 Industry Outlook
Pharm Exec's annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead ... Read more
|
|
|
| //Alliance Pharma (Chippenham, UK) appointed Nigel Clifford as an independent non-executive director, with immediate effect.//Germany's pharmaceutical industry trade body VFA announced that Birgit Fischer will remain Chief Executive until 2019.//Merck KGaA (Darmstadt, Germany) appointed Andreas Stickler to control the healthcare business sector, where he will be responsible for the operations of Merck's pharma division Merck Serono, biosimilars and allergy subsidiary Allergopharma. Roman Morten Werth will assume Mr Stickler's former position as Head of Mergers and Acquisitions.//Immune Pharmaceuticals (New York, NY) announced the appointment Dr Paul Nadler as acting Executive Vice President, Research & Development and Chief Medical Officer.//The Board of Directors of SCYNEXIS (Research Triangle Park, NC) appointed Marco Taglietti, M.D., as Chief Executive, effective April 1, 2015. // |
|
|
|
